A successful lab is at the heart of any thriving pharmaceutical or biotech company. But running a successful lab in the 21st century requires a complex skill set. You have to have deep technical understanding and project management expertise. You also have to juggle the many personalities of researchers, regulators, and organizational hierarchy. You must develop a clear and focused vision, be ruthlessly efficient with your resources, and be disciplined in your execution.
The fascinating topics covered ranged from laboratory organization and communication to bio-terrorism. ChronoWake has benefited greatly from this training course, increasing laboratory efficiency and maintaining compliance with regulatory requirements.
This workshop was also an excellent networking opportunity, connecting ChronoWake with high-level employees of global pharmaceutical and biotechnology corporations, potentially paving the way toward a future partnership or acquisition.
While our friends have been traveling and relaxing for the summer, the ChronoWake Team has been hard at work in the lab, ordering materials and equipment with our $15,000+ in funding. We have also been attending monthly advising meetings and receiving legal guidance as a part of Wharton VIP.
We’re happy to announce that we’ve been featured by University Startups, including a well-written article by Ashish Sharma. Additionally, our news feed has been added to Wharton Entrepreneurial Programs’ Entrepreneurial Advantage Blog. This increasing publicity has been fostering even more interest in our company.
We’re enthusiastic about the progress we’ve been making. It’s nothing short of exhilarating to witness the evolution of our product from a concept to a physical, functional entity!
Earlier today, Ryan Goldstein, President/CEO, met with the managing director of a large Philadelphia-based venture capital firm. Because of the great potential evident in our venture, ChronoWake has been offered pro bono legal services for intellectual property protection (patent filing), as well as full support in furthering our venture objectives.
So far, ChronoWake management has not had to concede any equity in the company (the founders are retaining 100% ownership). We are very enthusiastic about, and thankful for, the valuable services and support provided to us without cash or equity in return. We avidly anticipate a mutually beneficial partnership with this firm.